Latest Virus-like particle Stories

2014-06-10 12:32:11

LONDON, June 10, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Novavax, Inc. - Product Pipeline Review - 2014http://www.reportbuyer.com/pharma_healthcare/therapeutic/novavax_inc_product_pipeline_review_2013.html Novavax, Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Direct's, 'Novavax, Inc. - Product Pipeline Review - 2014', provides an overview of the Novavax, Inc.'s pharmaceutical research and development focus.This report provides...

2014-03-25 08:30:28

ROCKVILLE, Md., March 25, 2014 /PRNewswire/ -- VLP Therapeutics, Inc. ("VLP"), a Rockville-based biotechnology company focusing on the research and development of next generation antibody agents and therapeutic as well as preventive vaccines based upon a novel and proprietary i- VLP technology (which stands for "inserted alpha virus like particle"), today announced that Ryuji Ueno, M.D., Ph.D., Ph.D., Co-Founder and former Chair, Chief Executive Officer and Chief Scientific Officer of...

2014-03-07 12:25:48

Instrumentation Allows for High Resolution Mass and Size Analysis of Proteins, Antibody Aggregates, Viruses/Vaccines/VLPs, Polymers, and Nanoparticles SHOREVIEW, Minn., March 7, 2014 /PRNewswire/ -- TSI, a worldwide leader in precision measurement instrumentation, announces the launch of its new MacroIMS(TM) Macroion Spectrometer. The MacroIMS Macroion Mobility Spectrometer 3982 is a powerful new tool for rapid, high-resolution molecular size and mass analysis of macromolecules....

2014-01-29 00:20:55

SINGAPORE and ZURICH, January 29, 2014 /PRNewswire/ -- Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that their influenza vaccine (gH1-Qbeta) met its primary end point for immunogenicity (seroconversion based on haemaglutination inhibition titres according to FDA criteria) in the Phase 1 clinical trial in healthy Asian volunteers. The induced immune response showed good cross-reactivity to recent...

2014-01-23 23:05:00

GIA announces the release of a trend report on Virus-Like Particles (VLPs). Market for Virus-Like Particles (VLPs) is projected to witness growth led by technological advancements in vaccine development. San Jose, California (PRWEB) January 23, 2014 Virus-like particles (VLPs) bear high structural resemblance to viruses, though completely non-infectious in nature due to the absence of viral genetic material. Despite lacking DNA material, VLPs retain key immunological characteristics of...

Word of the Day
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'